Physician
Retina Consultants of Orange County, a Medical Corporation
Retina Consultants of Orange County, a Medical Corporation was paid $3.30M by Medicaid between Jan 2018 and Nov 2024, across 16 billing codes. Its largest line is J2777, Injection, faricimab-svoa, 0.1 mg — 40% of everything it billed.
33Billing provider infoRETINA CONSULTANTS OF ORANGE COUNTY, A MEDICAL CORPORATION
FULLERTON, CA 92835
FULLERTON, CA 92835
33aNPI1770539702assigned 05/25/2006
33bProvider typeRetina Specialist (Ophthalmology) Physician
28Total paid$3.30M
24GClaims29,097
24DCodes billed16
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Retina Specialist (Ophthalmology) Physician providers in California
Rank by total paid#7 of 45
Median peer was paid$55K
This provider vs. median60×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,871 | $60K | |
| 2019 | 2,217 | $54K | |
| 2020 | 2,356 | $94K | |
| 2021 | 3,350 | $167K | |
| 2022 | 3,811 | $227K | |
| 2023 | 6,732 | $1.05M | |
| 2024incomplete | 7,760 | $1.64M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 40% | 1,153 | 1,052 | $1.31M |
| 67028 | Intravitreal injection of a pharmacologic agent | 25% | 5,727 | 5,423 | $839K |
| J0178 | Injection, aflibercept, 1 mg | 19% | 949 | 927 | $612K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.6% | 7,549 | 7,164 | $284K |
| 92134 | 5.2% | 11,069 | 10,215 | $172K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 1,250 | 1,194 | $29K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 296 | 288 | $21K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 112 | 103 | $11K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 111 | 107 | $7K |
| 92235 | <1% | 160 | 121 | $5K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 120 | 117 | $3K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 45 | 45 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRANT, SCOTT (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Caring Smiles PLLC | Boise, ID | $402K |
| SW Grant PC | Meridian, ID | $93K |
| Smile Company, PLLC | Boise, ID | $887.70 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.